RW Investment Management’s Edwards Lifesciences EW Stock Holding History

RW Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$356K	Hold	3,936	–	–	0.03%	86
2026 Q1	$315K	Buy	+3,936	New	+$324K	0.03%	87
2025 Q3	$306K	Hold	3,936	–	–	0.03%	83
2025 Q2	$308K	Sell	3,936 -368	-9%	-$27.4K	0.03%	85
2025 Q1	$312K	Hold	4,304	–	–	0.04%	74
2024 Q4	$319K	Hold	4,304	–	–	0.04%	77
2024 Q3	$284K	Hold	4,304	–	–	0.04%	80
2024 Q2	$398K	Hold	4,304	–	–	0.05%	67
2024 Q1	$411K	Hold	4,304	–	–	0.06%	67
2023 Q4	$328K	Sell	4,304 -295	-6%	-$20.5K	0.05%	69
2023 Q3	$319K	Hold	4,599	–	–	0.06%	67
2023 Q2	$434K	Sell	4,599 -106	-2%	-$9.21K	0.09%	56
2023 Q1	$389K	Sell	4,705 -295	-6%	-$23.2K	0.11%	57
2022 Q4	$373K	Buy	+5,000	New	+$385K	0.15%	54

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

RW Investment Management's EW Position: Q2 2026 in Review

RW Investment Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 3,936 shares worth $356K. The position accounts for 0.03% of the portfolio, ranked #86.

RW Investment Management first reported a position in EW in Q4 2022 and has held it in 14 quarters since. The position peaked at $434K in Q2 2023. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

RW Investment Management held 3,936 shares of Edwards Lifesciences worth $356K as of Q2 2026.
RW Investment Management left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.03% of RW Investment Management's portfolio in Q2 2026, its #86 holding.
RW Investment Management first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 14 quarters since.
RW Investment Management's Edwards Lifesciences position peaked at $434K in Q2 2023.
1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on RW Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.